| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 101 | COMPOSITION FOR ANIMAL FEED ENHANCEMENT | US15945739 | 2018-04-04 | US20180279647A1 | 2018-10-04 | Daniel Burch |
| An animal feed supplement that includes dry Enterococcus faecium Fermentation Product, dry Bacillus subtilis Fermentation Product, dry Bacillus licheniformis Fermentation Product, dry Lactobacillus casei Fermentation Product, dry Lactobacillus plantarum Fermentation Product, dry Lactobacillus acidophilus Fermentation Product, dry Bifidobacterium bifidum Fermentation Product, dry Pediococcus acidilactici Fermentation Product, dry Pediococcus pentosaceus Fermentation Product; and dry Lactobacillus lactis Fermentation Product. | ||||||
| 102 | SWEETENER COMPOSITIONS | US15687355 | 2017-08-25 | US20180070621A1 | 2018-03-15 | Dennis Wong; Horst Krupp |
| A sweetener composition comprising xylose, a sugar alcohol and brown seaweed extract in solid form, preferably powdered or crystalline form. The sugar alcohol is preferably an erythritol and the brown seaweed extract is preferably obtained from Laminaria japonica. The sweetener composition can further comprise one or a combination of additional vitamins, minerals, probiotic cultures, and other plant-based extracts. | ||||||
| 103 | MULTI-SUPPLEMENT COMPOSITIONS | US14987584 | 2016-01-04 | US20160193306A1 | 2016-07-07 | Alexander B. Rabovsky; Begonia Yeeman Ho; Stephanie Y. Nielson; Nasser A. Fredj; Subhendu Nayak; Erin A. Stone |
| This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided. | ||||||
| 104 | PROBIOTIC COMPOSITIONS AND METHODS | US14380881 | 2013-02-27 | US20150044172A1 | 2015-02-12 | Rodrigo Carvalho Bicalho; Georgios Oikonomou; Andre Gustavo Vieira Teixeira |
| The present invention relates to probiotic compositions and methods of using such compositions. In particular, the present invention provides method of using Faecalibacterium spp. to improve weight gain, provide prophylaxis against diarrhea and/or improve feed efficiency in an animal. | ||||||
| 105 | Hypoglycemic effect enhancer | US13258064 | 2010-03-25 | US08889375B2 | 2014-11-18 | Yasuhiro Isa; Masaki Shimakawa; Hiroshi Ohno; Hideki Yamamura |
| A hypoglycemic effect enhancer for enhancing the activity of an α-glucosidase inhibitor, the enhancer comprising at least one kind of bacteria selected from the group consisting of bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria. | ||||||
| 106 | PROBIOTIC BIFIDOBACTERIAL COMPOSITION IN ACCORDANCE WITH SECRETOR BLOOD GROUP STATUS | US13519493 | 2010-12-28 | US20120301435A1 | 2012-11-29 | Pirjo Wacklin; Jaana Matto; Harri Makivuokko |
| The present invention relates to a microbial or probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals of non-secretor blood group phenotype. The present invention further relates to a method of tailoring a microbial or probiotic composition based on the bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals non-secretor blood group phenotype. | ||||||
| 107 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | US12091047 | 2006-10-06 | US20090263537A1 | 2009-10-22 | Joachim Schmitt; Gunther Boehm |
| The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides | ||||||
| 108 | Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients | US12091257 | 2006-09-22 | US20090028840A1 | 2009-01-29 | Sin Hyeog Im; Jae Seon So; Hwa Joong Yi |
| The present invention relates to a composition for preventing or treating arthritis, which comprises a lactic acid bacterium and collagen as major active ingredients. The present composition shows excellent prevention or treatment efficacies on arthritis of animal models. In addition, since the active ingredients used in the composition of this invention have been recognized to be safe to human, the present composition has considerable safety with enhanced immunomodulatory effect in patients with arthritis. | ||||||
| 109 | PROBIOTIC COMPOSITIONS AND METHODS | US15474723 | 2017-03-30 | US20170202887A1 | 2017-07-20 | Rodrigo Carvalho Bicalho; Georgios Oikonomou; Andre Gustavo Vieira Teixeira |
| The present invention relates to probiotic compositions and methods of using such compositions. In particular, the present invention provides method of using Faecalibacterium spp. to improve weight gain, provide prophylaxis against diarrhea and/or improve feed efficiency in an animal. | ||||||
| 110 | METHOD FOR STIMULATING THE INTESTINAL FLORA | US14973166 | 2015-12-17 | US20160100618A1 | 2016-04-14 | Günther BOEHM; Bernd STAHL; Jan KNOL |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
| 111 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | US14846120 | 2015-09-04 | US20160058806A1 | 2016-03-03 | Joachim SCHMITT; Günther BOEHM; Christopher BEERMANN |
| The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides. | ||||||
| 112 | Method for constructing novel bacterium belonging to the genus Bifidobacterium | US13577511 | 2011-02-21 | US08889120B2 | 2014-11-18 | Tomoyuki Sako; Mika Miura; Yasuhisa Shimakawa; Koji Miyazaki; Junji Fujimoto; Koichi Watanabe |
| A method for producing bacteria belonging to the genus Bifidobacterium having excellent viability even under various conditions with different environmental factors, novel bacteria belonging to the genus Bifidobacterium obtained by the method, and a method for detecting the bacteria are provided. By subculturing and storing bacteria belonging to the genus Bifidobacterium alternately in systems under conditions with different environmental factors, the bacteria belonging to the genus Bifidobacterium exhibiting excellent viability under all the conditions used for the alternate subculturing and storing can be produced. | ||||||
| 113 | METHOD FOR CONSTRUCTING NOVEL BACTERIUM BELONGING TO THE GENUS BIFIDOBACTERIUM | US13577511 | 2011-02-21 | US20120329059A1 | 2012-12-27 | Tomoyuki Sako; Mika Miura; Yasuhisa Shimakawa; Koji Miyazaki; Junji Fujimoto; Koichi Watanabe |
| A method for producing bacteria belonging to the genus Bifidobacterium having excellent viability even under various conditions with different environmental factors, novel bacteria belonging to the genus Bifidobacterium obtained by the method, and a method for detecting the bacteria are provided. By subculturing and storing bacteria belonging to the genus Bifidobacterium alternately in systems under conditions with different environmental factors, the bacteria belonging to the genus Bifidobacterium exhibiting excellent viability under all the conditions used for the alternate subculturing and storing can be produced. | ||||||
| 114 | HYPOGLYCEMIC EFFECT ENHANCER | US13258064 | 2010-03-25 | US20120014923A1 | 2012-01-19 | Yasuhiro Isa; Masaki Shimakawa; Hiroshi Ohno; Hideki Yamamura |
| A hypoglycemic effect enhancer for enhancing the activity of an α-glucosidase inhibitor, the enhancer comprising at least one kind of bacteria selected from the group consisting of bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria. | ||||||
| 115 | METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION | US12091050 | 2006-10-06 | US20090221486A1 | 2009-09-03 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising uronic acid oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 116 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US12091011 | 2006-10-06 | US20090220639A1 | 2009-09-03 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 117 | Method for Stimulating the Intestinal Flora | US12083612 | 2006-10-20 | US20090162323A1 | 2009-06-25 | Günther Boehm; Bernd Stahl; Jan Knol |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
| 118 | 肥満および肥満関連疾患の治療のためのプロバイオティクス組成物および方法 | JP2015533065 | 2013-08-12 | JP6286434B2 | 2018-02-28 | オルムステッド スティーブン フランシス |
| 119 | 肥満および肥満関連疾患の治療のためのプロバイオティクス組成物および方法 | JP2015533065 | 2013-08-12 | JP2015530406A | 2015-10-15 | スティーブン フランシス オルムステッド |
| 本発明は、必要がある哺乳類において、肥満、糖尿病、および関連疾患を、症状および徴候を改善するかまたは減少させ、治療する方法および組成物を提供し、前記方法は、異なっているが相補的な炭水化物代謝経路を持つプロバイオティクス微生物の混合物を含有する薬学的に許容可能な組成物の有効量を、肥満、糖尿病、または心臓血管疾患の少なくとも1つの徴候または症状を改善、減少、または治療するために十分な期間、投与することを含む。所望の性質を有する組成物、およびそれらの薬物および栄養配合物での使用のための方法が提供される。【選択図】なし | ||||||
| 120 | 新規ビフィドバクテリウム属細菌の作出方法 | JP2012501772 | 2011-02-21 | JP5643285B2 | 2014-12-17 | 知行 左古; みか 三浦; 島川 康久; 康久 島川; 幸司 宮崎; 藤本 淳治; 淳治 藤本; 渡辺 幸一; 幸一 渡辺 |
QQ群二维码
意见反馈
意见反馈